One must raise awareness, promote safe treatments, and protect patients from risks
Cayenne pepper
In the meantime, the GLP-1 Collective is raising money to help people pay for their prescriptions
The efficacy and safety of the new GLP-1 medicines continues to garner interest and will be discussed #ADA2024 Here is an updated safety-focused summary of the field and where it might be headed @DiabetesCareADA #T2D #obesity pic.twitter.com/rtEQYtHQG0 Daniel J Drucker (@DanielJDrucker) June 6, 2024 Investigational GLP-1 medicines in the clinic Late-stage investigational GLP-1 medicines for type 2 diabetes and obesity include new molecules like retatrutide and orforglipron, showing potential differentiation from semaglutide and tirzepatide through better tolerability, greater weight loss, Hb A 1c reduction, and targeted outcomes
GLP-1 medicationslike Wegovy and Zepbound while not explicitly prescribed for menopause, can be a big help for those trying to lose weight during it
Insulins Based on learning about the sulfonylurea interaction with Ozempic, one could probably guess that insulins would be a problem, too